On October 8, GENFLEET-B fell 6.61% in regular trading, trading at 31.5 Hong Kong dollars per share, with turnover of 1.4673 million Hong Kong dollars. The decline came as the stock faced dual pressure from a major shareholder's stake reduction and insufficient buyback support.

On September 24, major shareholder Ourea Biotech HK Limited sold 6 million shares on-market at an average price of 27.3 Hong Kong dollars per share, involving approximately 164 million Hong Kong dollars. Its long position ratio dropped from 6.34% to 4.64%, falling below the 5% disclosure threshold. The market interpreted this as institutional investors turning cautious on the company's near-term valuation.

Meanwhile, although the company repurchased approximately 988,000 H shares in September and held them as treasury shares, the buyback scale was relatively limited and failed to effectively offset the selling pressure from the stake reduction, triggering market concerns about short-term valuation confidence.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)